J Kojima Selected Research

J Kojima Research Topics

Disease

3	Breast Neoplasms (Breast Cancer) 11/2001 - 01/2001
2	Hypoxia (Hypoxemia) 01/2021 - 01/2001
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2010 - 09/2010
2	Fibrosis (Cirrhosis) 07/2007 - 08/2001
2	Hyponatremia 01/2005 - 05/2004
2	Neoplasms (Cancer) 11/2001 - 05/2001
2	Asthma (Bronchial Asthma) 05/2000 - 04/2000
2	Hypersensitivity (Allergy) 05/2000 - 04/2000
1	Inflammation (Inflammations) 01/2021
1	Endometriosis 01/2021
1	Sclerosis 07/2007
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2007
1	Wasting Syndrome (Wasting Disease) 05/2004
1	Dehydration (Water Stress) 05/2004
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 05/2004
1	Inappropriate ADH Syndrome (SIADH) 05/2004
1	Body Weight (Weight, Body) 05/2002
1	Pain (Aches) 01/2002
1	Hemolysis 01/2002
1	Phlebitis 01/2002
1	Tachypnea 08/2001
1	Multiple Trauma (Multiple Injuries) 01/2001
1	Lymphatic Metastasis 01/2001
1	Neoplasm Metastasis (Metastasis) 01/2001
1	Ischemia 01/2001
1	Hypovolemia 01/2001
1	Burns 01/2001
1	Endotoxemia 01/2001
1	Atherosclerosis 11/2000
1	Chronic Hepatitis (Chronic Active Hepatitis) 07/2000
1	Hepatocellular Carcinoma (Hepatoma) 07/2000
1	Liver Diseases (Liver Disease) 07/2000
1	MPTP Poisoning 05/2000
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2000
1	Vomiting 04/2000
1	Spasm (Spasms) 04/2000
1	Polyuria 03/2000

Drug/Important Bio-Agent (IBA)

5	Theophylline (Theon)FDA LinkGeneric 08/2001 - 03/2000
4	SaltsIBA 12/2010 - 04/2000
2	SodiumIBA 01/2005 - 05/2004
2	Aminophylline (Carine)FDA LinkGeneric 05/2000 - 04/2000
2	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 05/2000 - 04/2000
1	Thrombin FDA Link 01/2021
1	VimentinIBA 01/2021
1	ProstaglandinsIBA 01/2021
1	CXC ChemokinesIBA 01/2021
1	Proteinase-Activated ReceptorsIBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2010
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2007
1	CytokinesIBA 07/2007
1	Vasopressins (Vasopressin)IBA 05/2004
1	Hypotonic SolutionsIBA 05/2004
1	Nonesterified Fatty Acids (NEFA)IBA 05/2002
1	SolutionsIBA 01/2002
1	TinIBA 11/2001
1	Human Serum Albumin FDA LinkGeneric 11/2001
1	Colloids (Colloid)IBA 11/2001
1	doxifluridineIBA 05/2001
1	Etoposide (VP 16)FDA LinkGeneric 05/2001
1	Thymidine PhosphorylaseIBA 05/2001
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 05/2001
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 05/2001
1	AnthracyclinesIBA 05/2001
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2001
1	Multidrug Resistance-Associated ProteinsIBA 05/2001
1	Lipopolysaccharide ReceptorsIBA 01/2001
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2001
1	EndotoxinsIBA 01/2001
1	VLDL LipoproteinsIBA 11/2000
1	oxidized low density lipoproteinIBA 11/2000
1	pitavastatin (itavastatin)FDA Link 11/2000
1	InterferonsIBA 07/2000
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 05/2000
1	Therapeutic UsesIBA 05/2000

Therapy/Procedure

2	Punctures 09/2010 - 01/2005
1	Intravenous Injections 07/2007
1	Fluid Therapy (Oral Rehydration Therapy) 05/2004
1	Lymph Node Excision (Lymph Node Dissection) 11/2001
1	Drug Therapy (Chemotherapy) 05/2001
1	Combination Drug Therapy (Combination Chemotherapy) 05/2001
1	Segmental Mastectomy (Lumpectomy) 01/2001
1	Radiotherapy 01/2001
1	Therapeutics 07/2000
1	Injections 04/2000